Publication | Closed Access

Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo

Tumor BiologyAnti-tumor EffectPancreatic CancerMedicinePharmacologyCancer Cell BiologyAnti-cancer AgentCancer TreatmentOncologyCell BiologyCancer Research